The Producers Life Insurance coverage Firm lifted its holdings in ZoomInfo Applied sciences Inc. (NASDAQ:ZI – Get Ranking) by 17.3% within the third quarter, based on its most up-to-date 13F submitting with the SEC. The agency owned 1,086,279 shares of the corporate’s inventory after buying a further 159,948 shares throughout the quarter. The Producers Life Insurance coverage Firm owned about 0.27% of ZoomInfo Applied sciences value $45,254,000 as of its most up-to-date SEC submitting.
A number of different hedge funds have additionally lately purchased and bought shares of the inventory. US Bancorp DE elevated its place in shares of ZoomInfo Applied sciences by 16.2% within the first quarter. US Bancorp DE now owns 13,497 shares of the corporate’s inventory valued at $807,000 after buying a further 1,879 shares over the past quarter. Cambridge Funding Analysis Advisors Inc. raised its holdings in shares of ZoomInfo Applied sciences by 78.6% within the 1st quarter. Cambridge Funding Analysis Advisors Inc. now owns 11,357 shares of the corporate’s inventory valued at $678,000 after buying a further 4,999 shares throughout the interval. PNC Monetary Companies Group Inc. lifted its stake in ZoomInfo Applied sciences by 47.2% within the 1st quarter. PNC Monetary Companies Group Inc. now owns 1,925 shares of the corporate’s inventory valued at $115,000 after buying a further 617 shares over the past quarter. Panagora Asset Administration Inc. grew its holdings in ZoomInfo Applied sciences by 294.1% throughout the first quarter. Panagora Asset Administration Inc. now owns 24,918 shares of the corporate’s inventory value $1,489,000 after buying a further 18,596 shares throughout the interval. Lastly, BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp grew its holdings in ZoomInfo Applied sciences by 10.4% throughout the first quarter. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp now owns 43,573 shares of the corporate’s inventory value $2,603,000 after buying a further 4,118 shares throughout the interval. 84.96% of the inventory is presently owned by institutional buyers and hedge funds.
Table of Contents
Insider Transactions at ZoomInfo Applied sciences
In associated information, CEO Henry Schuck bought 1,000,000 shares of the corporate’s inventory in a transaction that occurred on Monday, January ninth. The inventory was bought at a mean worth of $25.54, for a complete worth of $25,540,000.00. Following the sale, the chief govt officer now owns 13,288,001 shares within the firm, valued at roughly $339,375,545.54. The transaction was disclosed in a doc filed with the Securities & Trade Fee, which is accessible by this hyperlink. Insiders personal 9.70% of the corporate’s inventory.
Wall Avenue Analysts Forecast Progress
A number of analysis companies lately commented on ZI. Raymond James decreased their worth goal on shares of ZoomInfo Applied sciences from $65.00 to $41.00 in a analysis observe on Wednesday, November 2nd. Financial institution of America lower shares of ZoomInfo Applied sciences from a “purchase” ranking to a “impartial” ranking and dropped their goal worth for the corporate from $35.00 to $34.00 in a analysis report on Wednesday, January 4th. Mizuho dropped their worth goal on ZoomInfo Applied sciences from $50.00 to $45.00 and set a “purchase” ranking for the corporate in a analysis report on Thursday, December eighth. UBS Group lower their goal worth on shares of ZoomInfo Applied sciences from $37.00 to $34.00 in a analysis report on Friday. Lastly, Morgan Stanley lowered their goal worth on ZoomInfo Applied sciences from $60.00 to $38.00 and set an “chubby” ranking for the corporate in a report on Wednesday, December seventh. Two equities analysis analysts have rated the inventory with a maintain ranking and sixteen have issued a purchase ranking to the inventory. Primarily based on knowledge from MarketBeat, the inventory presently has a consensus ranking of “Average Purchase” and a consensus worth goal of $43.33.
ZoomInfo Applied sciences Inventory Up 1.0 %
ZI opened at $25.89 on Friday. ZoomInfo Applied sciences Inc. has a 12 month low of $23.29 and a 12 month excessive of $61.44. The corporate has a present ratio of 1.28, a fast ratio of 1.28 and a debt-to-equity ratio of 0.56. The enterprise’s 50-day transferring common worth is $28.10 and its 200-day transferring common worth is $37.19. The corporate has a market cap of $10.45 billion, a P/E ratio of 56.28, a P/E/G ratio of 1.82 and a beta of 0.97.
ZoomInfo Applied sciences (NASDAQ:ZI – Get Ranking) final introduced its quarterly earnings outcomes on Tuesday, November 1st. The corporate reported $0.12 earnings per share (EPS) for the quarter, lacking analysts’ consensus estimates of $0.13 by ($0.01). The enterprise had income of $287.60 million for the quarter, in comparison with analysts’ expectations of $277.90 million. ZoomInfo Applied sciences had a internet margin of 18.15% and a return on fairness of seven.92%. On common, equities analysts anticipate that ZoomInfo Applied sciences Inc. will submit 0.45 EPS for the present 12 months.
ZoomInfo Applied sciences Firm Profile
ZoomInfo Applied sciences Inc, by its subsidiaries, gives go-to-market intelligence and engagement platform for gross sales and advertising and marketing groups in the US and internationally. The corporate’s cloud-based platform gives data on organizations and professionals to assist customers determine goal clients and determination makers, get hold of frequently up to date predictive lead and firm scoring, monitor shopping for alerts and different attributes of goal firms, craft messages, have interaction by automated gross sales instruments, and monitor progress by the deal cycle.
Additional Studying
Wish to see what different hedge funds are holding ZI? Go to HoldingsChannel.com to get the newest 13F filings and insider trades for ZoomInfo Applied sciences Inc. (NASDAQ:ZI – Get Ranking).
This on the spot information alert was generated by narrative science expertise and monetary knowledge from MarketBeat with the intention to present readers with the quickest and most correct reporting. This story was reviewed by MarketBeat’s editorial workforce previous to publication. Please ship any questions or feedback about this story to contact@marketbeat.com.
Earlier than you take into account ZoomInfo Applied sciences, you will need to hear this.
MarketBeat retains monitor of Wall Avenue’s top-rated and greatest performing analysis analysts and the shares they advocate to their purchasers every day. MarketBeat has recognized the 5 shares that prime analysts are quietly whispering to their purchasers to purchase now earlier than the broader market catches on… and ZoomInfo Applied sciences wasn’t on the record.
Whereas ZoomInfo Applied sciences presently has a “Average Purchase” ranking amongst analysts, top-rated analysts imagine these 5 shares are higher buys.
